major depressive disorder

Fluoxetine is an antidepressant used for the treatment of MDD, OCD, bulimia nervosa, panic disorder, with or without agoraphobia

The Phase-2 clinical trial of Ropanicant (SUVN-911) is for the treatment of moderate to severe Major Depressive Disorder (MDD)…

Some of the key unmet needs in the MDD market are for products that have improved efficacy and safety profiles and that can show…

Zuranolone is being evaluated as a potential 14-day, rapid-acting, once-daily, oral medication to treat major depressive disorder…

To reach $7.9 billion by 2029 at a compound annual growth rate (CAGR) of 7.1 per cent

The drug indicated to treat adults with major depressive disorder and acute suicidal ideation or behaviour reportedly begins…

Rexulti was shown to reduce the occurrence of symptoms of schizophrenia compared to placebo (inactive tablet)

These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research…

The granted claims of the patents include the class of selective alpha-4-beta-two compounds discovered by Suven and are being…